--- title: "5-Amino-1MQ Guide: NNMT, NAD+ and Metabolic Research - PeptideSupermarket®" description: "Learn how 5-Amino-1MQ is studied for NNMT inhibition, NAD+ metabolism and adipose tissue research, with cautions for peptides SA buyers." url: "https://peptidesupermarket.co.za/research/5-amino-1mq-guide-nnmt-nad-and-metabolic-research" site: "PeptideSupermarket®" country: "South Africa" --- [Home](https://peptidesupermarket.co.za) › [Research](https://peptidesupermarket.co.za/research) › 5-Amino-1MQ Guide: NNMT, NAD+ and Metabolic Research [Back to Guides](https://peptidesupermarket.co.za/research/category/guides) [Guides](https://peptidesupermarket.co.za/research/category/guides) [5-Amino 1MQ](https://peptidesupermarket.co.za/research/peptide/5-amino-1mq) # 5-Amino-1MQ Guide: NNMT, NAD+ and Metabolic Research 5-Amino-1MQ is a small-molecule NNMT inhibitor studied for NAD+ metabolism, mitochondrial function and adipose tissue biology. Human evidence remains limited. Published 16 Aug 2026 7 min read Reference-backed All content is for educational and research reference purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. [Read our full disclosure](https://peptidesupermarket.co.za/disclosure). 5-Amino-1MQ has become a frequent topic in peptide and longevity discussions because it targets nicotinamide N-methyltransferase, usually shortened to NNMT. That enzyme sits in an interesting position between nicotinamide metabolism, NAD+ biology and cellular energy regulation. The first point to get clear is that 5-Amino-1MQ is not technically a peptide. It is a small-molecule NNMT inhibitor. It is often listed alongside peptides because it appears in metabolic optimisation and longevity research conversations, but its structure and mechanism are different from peptide compounds. The current research picture is promising in places, especially in preclinical obesity and ageing models, yet still early. Human evidence is extremely limited, and there is no well-established human therapeutic dose. ## What 5-Amino-1MQ is studied for 5-Amino-1MQ is mainly discussed in relation to NAD+ metabolism, mitochondrial function, cellular repair and metabolic research. Its research profile is preclinical, which means most of the useful evidence comes from laboratory work and animal models rather than controlled human trials. The compound is described as an NNMT inhibitor. By inhibiting NNMT, researchers are exploring whether nicotinamide can be preserved for pathways linked with NAD+ availability and cellular energy production. In plain terms, the research question is whether changing NNMT activity can influence how cells manage energy, repair and fat storage. That is why 5-Amino-1MQ is often mentioned alongside NAD+, NMN, NR and mitochondrial compounds such as MOTS-c. ## How NNMT connects to NAD+ metabolism NAD+ is central to cellular metabolism and mitochondrial energy production. The body can recycle nicotinamide, a form of vitamin B3, through the NAD+ salvage pathway. NNMT provides a competing pathway. It methylates nicotinamide to form 1-methylnicotinamide. This is a normal biological process and should not be described as inherently harmful. The research interest comes from observations that increased NNMT expression has been seen in adipose tissue in some metabolic and obesity-related studies. That has led researchers to ask whether inhibiting higher NNMT activity could affect energy metabolism, NAD+ availability and fat-cell biology. ## How 5-Amino-1MQ is thought to work The proposed mechanism is enzyme inhibition. 5-Amino-1MQ inhibits the NNMT enzyme systemically, which may reduce nicotinamide methylation and help maintain higher cellular NAD+ levels. This is different from supplying NAD+ or an NAD+ precursor directly. NMN, NR, niacin and related compounds are studied as contributors to NAD+ precursor pools. 5-Amino-1MQ is being explored for its potential to change how nicotinamide is metabolised. Compound typeMain research angleNAD+, NMN, NR and niacinProvide or contribute to NAD+ precursor availability5-Amino-1MQInhibits NNMT, an enzyme involved in nicotinamide metabolismMOTS-cStudied in relation to cellular energy sensing, AMPK signalling and metabolic adaptation This distinction matters because a plausible mechanism does not automatically establish a clinical effect in humans. Pharmacokinetics, tissue distribution, clearance and actual enzyme inhibition in target tissues all matter. ## Why adipose tissue research gets attention One of the strongest reasons 5-Amino-1MQ attracts attention is its link with adipose tissue research. Preclinical work has connected NNMT activity with energy metabolism and fat-cell biology. A 2018 mouse obesity study by Neelakantan and colleagues reported that diet-induced obese mice given 5-Amino-1MQ showed 5.1% weight loss and a 30% reduction in adipocyte size at 60 mg/kg/day. The reference data notes that this corresponds to an approximate human equivalent of 5 mg/kg/day using FDA allometric scaling, but that conversion should not be treated as a human dosing protocol. A 2024 aged-mouse study reported improved muscle function, including a 40% grip-strength improvement in sedentary mice and 60% with exercise at 10 mg/kg/day subcutaneously for eight weeks. The same reference notes that no adverse effects were observed in that study. These findings are interesting, but they remain preclinical. They should not be translated into claims that 5-Amino-1MQ produces the same effects in people. [Research 5-Amino-1MQ South Africa](https://peptidesupermarket.co.za/peptide/5-amino-1mq) ## Is 5-Amino-1MQ a fat-loss compound? 5-Amino-1MQ is often discussed in weight-management circles because of animal research involving diet-induced obesity and adipose tissue. The evidence does not support presenting it as an established fat-loss treatment. Its proposed mechanism is closer to cellular metabolism and energy expenditure than direct appetite suppression. This separates it from appetite-focused medications such as GLP-1 receptor agonists. The key limitation is the lack of adequate controlled human trials. Without those data, claims about meaningful human fat loss, optimal use or long-term outcomes remain uncertain. > 5-Amino-1MQ is best understood as an experimental metabolic research compound, not a proven human weight-loss or NAD+-boosting treatment. ## The dosing problem in 5-Amino-1MQ discussions One of the biggest issues around 5-Amino-1MQ is the enormous variation in online dosing claims. Some references discuss microgram quantities, while others discuss milligram quantities. Those are not small differences. They can differ by 100 times or more. The available profile data also notes that injectable protocols vary widely and that unit confusion between micrograms and milligrams is a serious risk. This is one reason dosing claims should be treated with caution. There is currently no well-established human therapeutic dose for 5-Amino-1MQ. Animal doses cannot be turned into self-experimentation instructions, and IC50 values alone do not tell us what oral or injected amount would produce a desired concentration in human adipose tissue. A 2021 rat pharmacokinetics study reported 38.4% oral bioavailability, with a half-life of 6.9 hours orally and 3.8 hours intravenously. Those findings support the idea that oral administration can be studied, but they do not establish a human protocol. ## What about microdosing for NAD+? The idea of using very small quantities of 5-Amino-1MQ to “boost NAD+” is common online. The mechanism does not prove that tiny exposures meaningfully inhibit NNMT in human tissues. This does not prove microdosing has no biological effect. It means the evidence is not strong enough to establish what exposure is effective in humans, or whether the effect is clinically meaningful. For a research-focused buyer, this distinction is important. Mechanistic plausibility is useful, but it is not the same as demonstrated human benefit. ## 5-Amino-1MQ and mitochondrial function Because NAD+ is linked with mitochondrial energy production, 5-Amino-1MQ is often discussed in relation to mitochondrial function and cellular energy metabolism. The reference profile describes research interest in improved mitochondrial efficiency, cellular repair pathways and insulin sensitivity. The underlying logic is that enhanced NAD+ availability may support sirtuins and other pathways involved in DNA repair, cellular maintenance and stress resistance. These are longevity-adjacent mechanisms, and much of the work remains preclinical. Claims about enhanced energy, improved metabolic flexibility or body-composition changes should therefore be framed as research interests rather than established human outcomes. ## Why 5-Amino-1MQ is often paired with MOTS-c 5-Amino-1MQ and MOTS-c frequently appear in the same metabolic research discussions, although they work differently. MOTS-c is studied in relation to cellular energy sensing, AMPK signalling and metabolic adaptation. 5-Amino-1MQ targets NNMT. Theoretical combinations involving NAD+ support, MOTS-c and 5-Amino-1MQ are experimental concepts. They should not be described as clinically validated protocols. ## Safety considerations and research cautions The reference profile lists generally minimal side effects, with occasional mild gastrointestinal adjustment and possible sleep interference if used late in the day. It also flags stop signs such as severe gastrointestinal upset, persistent nausea, unusual fatigue, headaches, dizziness, sleep disturbance, allergic-type reactions and significant mood changes or anxiety. Contraindication notes include pregnancy or breastfeeding, and pre-existing metabolic conditions where healthcare input would be needed. These points should be treated as cautionary research information, not as clearance for human use. Long-term human safety remains poorly established. The most responsible position is to view 5-Amino-1MQ as a compound for research settings, with product identity and documentation carrying particular weight. [Peptide Supermarket South Africa](https://peptidesupermarket.co.za/peptide/5-amino-1mq) ## How to compare 5-Amino-1MQ suppliers in South Africa For readers comparing peptides SA listings, price should not be the only factor. 5-Amino-1MQ is already difficult to evaluate because the human evidence base is limited. Weak documentation makes that problem worse. Look for clear product identity, concentration information, batch documentation, independent testing where available and transparent supplier details. Search terms like “buy peptides SA” and “cheap peptides” can surface many options, but low price alone does not prove good value. If you are deciding where to buy peptides for research use, compare listings side by side rather than relying on a single supplier page. You can use the PeptideSupermarket® comparison hub to check current South African options: [Compare Peptide Prices in South Africa](https://peptidesupermarket.co.za/peptide/5-amino-1mq) ## Frequently asked questions ### Is 5-Amino-1MQ actually a peptide? No. 5-Amino-1MQ is not technically a peptide. It is a small-molecule NNMT inhibitor that is often grouped with peptides because of its role in metabolic and longevity research discussions. ### What is 5-Amino-1MQ used for in research? It is studied for NAD+ metabolism, mitochondrial function, cellular repair, adipose tissue biology, insulin sensitivity and metabolic research. Most of the evidence remains preclinical. ### Does 5-Amino-1MQ increase NAD+? 5-Amino-1MQ is investigated for its potential to maintain higher cellular NAD+ levels by inhibiting NNMT, which is involved in nicotinamide metabolism. Human evidence is still limited. ### Is 5-Amino-1MQ proven for fat loss? No. Animal obesity models have reported reductions in body weight and adipocyte size, but that does not establish proven fat-loss effects in humans. ### What is the half-life of 5-Amino-1MQ? The supplied rat pharmacokinetic data reports a half-life of about 6.9 hours orally and 3.8 hours intravenously. These figures come from animal research and should not be treated as human dosing guidance. ### Why are 5-Amino-1MQ dosing claims so inconsistent? There is no well-established human therapeutic dose. Online claims often mix animal data, IC50 values and inconsistent units, including micrograms versus milligrams, which can create major interpretation problems. ### Where can I compare 5-Amino-1MQ prices in South Africa? You can compare current research-product listings through the PeptideSupermarket® price comparison page: [Compare Peptide Prices in South Africa](https://peptidesupermarket.co.za/peptide/5-amino-1mq) ## Final thoughts 5-Amino-1MQ is interesting because it targets NNMT rather than acting as another NAD+ precursor. That gives it a distinct research angle linking nicotinamide metabolism, NAD+ biology, mitochondrial function and adipose tissue. The evidence still needs perspective. Preclinical findings are encouraging in selected models, but human dosing, effectiveness, long-term safety and practical use remain poorly established. This content is for research and educational purposes only. It is not medical advice and should not be used to guide human consumption, self-administration, diagnosis or treatment. For research buyers comparing peptide supplier SA options, start with product transparency and documentation, then compare pricing. To find the best-value current listing, visit [PeptideSupermarket®’s peptide price comparison page](https://peptidesupermarket.co.za/peptide/5-amino-1mq) Price Comparison ### Compare 5-Amino 1MQ prices across the UK Side-by-side prices from every trusted UK supplier stocking 5-Amino 1MQ. [Compare prices](https://peptidesupermarket.co.za/peptide/5-amino-1mq) [All articles](https://peptidesupermarket.co.za/research) Share copied = false, 2000)" aria-label="Copy link" class="w-8 h-8 rounded-full bg-bg-light hover:bg-primary hover:text-white text-text-muted flex items-center justify-center transition-colors cursor-pointer relative"> ### Featured Peptide #### 5-Amino 1MQ Regenerative peptide for tissue repair [Compare prices](https://peptidesupermarket.co.za/peptide/5-amino-1mq) ### More Guides [Browse all guides](https://peptidesupermarket.co.za/research/category/guides) Keep Reading ## Related articles Guides ### GHK-Cu vs Regular Skincare Peptides: What's the Difference? GHK-Cu is a copper-binding peptide with a broader skin repair research profile than many cosmetic peptides. Here is how it compares with Matrixyl, Argireline, SNAP-8 and similar ingredients. 9 min read [GHK-Cu vs Regular Skincare Peptides: What's the Difference?](https://peptidesupermarket.co.za/research/ghk-cu-vs-regular-skincare-peptides-whats-the-difference) Guides ### 30mg vs 60mg Retatrutide: what the label actually means A 60mg Retatrutide product contains twice the stated peptide quantity of a 30mg product, but that does not make it twice as effective or automatically better value. Here is how to read the numbers properly. 7 min read [30mg vs 60mg Retatrutide: what the label actually means](https://peptidesupermarket.co.za/research/30mg-vs-60mg-retatrutide-what-the-label-actually-means) Guides ### Ipamorelin guide: mechanism, benefits, stacking and safety A research-focused guide to Ipamorelin, covering its ghrelin receptor mechanism, growth hormone pulses, CJC-1295 NoDAC pairing, reported benefits, cycling logic and safety caveats. 10 min read [Ipamorelin guide: mechanism, benefits, stacking and safety](https://peptidesupermarket.co.za/research/ipamorelin-guide-mechanism-benefits-stacking-and-safety) --- *Add `.md` to any page URL on peptidesupermarket.co.za for its Markdown version. Index of the site: https://peptidesupermarket.co.za/llms.txt - full text: https://peptidesupermarket.co.za/llms-full.txt.*